Probiotic

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(Redirected from Probiotics)
Jump to: navigation, search

Probiotics are microorganisms that are believed to provide health benefits when consumed.

Health effects[edit | edit source]

  • Some bacteria species have been shown to inhibit pathogens in the gut[1] through competition or by producing their own antibiotics.
  • Probiotics can reduce histamines levels, or increase them.[citation needed]

Efficacy[edit | edit source]

Probiotics should be taken with or immediately before a meal, ideally with 1-2% milk.[citation needed]

Evidence for Commercial Probiotics[edit | edit source]

Mutaflor[edit | edit source]

E. Coli Nissle 1917 (Mutaflor)[citation needed]

Symbioflor-2[edit | edit source]

E. Coli G1-G10 6 species[citation needed]

Prescript Assist[edit | edit source]

Prescript Assist is a commercial probiotic containing 28 soil based bacteria.[citation needed]

Miyarisan[edit | edit source]

Miyarisan is a Japanese probiotic containing clostridium butyricum,[citation needed] a species that consumes lactic acid and produces butyrate.[citation needed]

Advanced Orthomolecular Research AOR, Advanced Series, Probiotic-3[edit | edit source]

Clostridium butyricum, Streptococcus faecalis, Bacillus mesentericus[citation needed]

Align[edit | edit source]

Bifidobacterium infantis 35624[citation needed]

Culturelle[edit | edit source]

Lactobacillus Rhamnosus GG[citation needed]

Bifido/Maximus[edit | edit source]

Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus rhamnosus, Lactobacillus salivarius, Lactobacillus gasseri[citation needed]

Enterogermina[edit | edit source]

Bacillus clausii[citation needed]

Yakult[edit | edit source]

Lactobacillus casei Shirota

DanActive[edit | edit source]

Lactobacillus casei Danone

Bioflorin[edit | edit source]

Enterococcus faecium SF 68[citation needed]

BioGaia[edit | edit source]

Lactobacillus reuteri[citation needed] produces vitamin B12

Evidence for specific strains[edit | edit source]

Bifidobacteria[edit | edit source]

Cost per Billion CFU can vary from 1 cent to $1.62.[citation needed] A recent study found 15/16 commercial offerings in California were mislabeled (i.e. different strain than listed).[citation needed]

Bifidobacterium infantis 35624[edit | edit source]

One study found that 6-8 weeks of Bifidobacterium infantis supplementation reduced C-reactive protein, TNF-alpha and IL-6 levels in chronic fatigue syndrome patients.[2] Another found that B. infantis boosted serotonin levels in the brain.[citation needed]

Commercial probiotics without evidence[edit | edit source]

These are likely harmful because they are known to kill E. coli that is very low in CFS patients.

Common Yogurts[edit | edit source]

Lactobacillus Acidophilus[citation needed]

Suspected to be effective but lacking studies[edit | edit source]

GeneralBiotics Equilibrium[citation needed] 115 strains - none are lactobacillus or bifidobacteria.

Typical Probiotics sold in Health Food Stores[edit | edit source]

Lactobacillus Acidophilus[citation needed] - often kill off the bacteria that was greatly reduced by CFS. Further unbalance the microbiome.

Megasporebiotic[edit | edit source]

Not sufficient research published[citation needed]

GcMAF Bravo[edit | edit source]

"“Streptococci, lactobacilli, bifidobacteria, lactococci, yeasts” - no research, no details of strains[citation needed]

Lactobacillus[edit | edit source]

Notable studies[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. Travers, Marie-Agnès; Florent, Isabelle; Kohl, Linda; Grellier, Philippe (September 28, 2011). "Probiotics for the Control of Parasites: An Overview". Journal of Parasitology Research. Retrieved March 2, 2021.
  2. Groeger, David; O'Mahony, Liam; Murphy, Eileen F.; Bourke, John F.; Dinan, Timothy G.; Kiely, Barry; Shanahan, Fergus; Quigley, Eamonn M. M. (August 2013), "Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut", Gut Microbes, 4 (4): 325–339, doi:10.4161/gmic.25487, ISSN 1949-0984, PMID 23842110
  3. Roman, P.; Carrillo-Trabalón, F.; Sánchez-Labraca, N.; Cañadas, F.; Estévez, A.F.; Cardona, D. (June 15, 2018). "Are probiotic treatments useful on fibromyalgia syndrome or chronic fatigue syndrome patients? A systematic review". Beneficial Microbes. 9 (4): 603–611. doi:10.3920/bm2017.0125. ISSN 1876-2883.
  4. Corbitt, M; Campagnolo, N; Staines, D; Marshall-Gradisnik, S (2018), "A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)", Probiotics Antimicrob Proteins, doi:10.1007/s12602-018-9397-8

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.